The founder of Pakistan Tehreek-e-Insaf (PTI) has been administered an Anti-VEGF intravitreal injection at the Pakistan Institute of Medical Sciences (PIMS), according to hospital authorities. The treatment is part of managing an eye-related medical condition.
Officials at PIMS confirmed the procedure was carried out successfully under medical supervision.
What Is an Anti-VEGF Intravitreal Injection?
Anti-VEGF injections are commonly used to treat eye conditions that affect the retina and vision, such as:
- Age-related macular degeneration (AMD)
- Diabetic retinopathy
- Retinal vein occlusion
The medication works by blocking vascular endothelial growth factor (VEGF), which helps reduce abnormal blood vessel growth and prevent further vision loss.
Hospital Statement
The PIMS Emergency Department stated that the procedure went smoothly and that the patient is under routine post-injection observation.
Moreover, doctors emphasized that Anti-VEGF injections are standard, widely used treatments in ophthalmology with a strong safety record when administered in clinical settings.
Importance of Timely Treatment
Early intervention with Anti-VEGF therapy can slow vision deterioration and improve quality of life for patients with retinal diseases. Experts recommend regular monitoring and follow-up to ensure optimal outcomes.
At the same time, patients should report any unusual symptoms post-injection, such as eye pain, redness, or vision changes, to their healthcare provider immediately.
Outlook
The PTI founder is expected to recover well following the injection, with further follow-up appointments scheduled to monitor progress.
Overall, this procedure highlights the effectiveness of Anti-VEGF therapy in managing serious eye conditions and preserving vision.
Stay with Faiz.tv for updates on political figures’ health, medical developments, and ophthalmology news.
